logo

InMed Pharmaceuticals Inc (INM) Stock: A Year of Market Movement, Down and Up

ALXO Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. InMed Pharmaceuticals Inc’s current trading price is -66.48% away from its 52-week high, while its distance from the 52-week low is 117.98%. The stock’s price range over this period has fluctuated between $2.41 and $15.70. The company, operating within the financial sector, had a trading volume of approximately 24.59 million for the day, which was noticeably higher than the average daily share volume of 43410.0 over the last 3 months.

InMed Pharmaceuticals Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $15.70 on 08/20/24, while the lowest value for the same period was recorded at $2.41 on 08/06/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

InMed Pharmaceuticals Inc (INM) has experienced a quarterly rise of 6.09% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.81M and boasts a workforce of 13 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.99, with a change in price of -2.25. Similarly, InMed Pharmaceuticals Inc recorded 284,991 in trading volume during the last 100 days, posting a change of -29.51%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for INM stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.07.

INM Stock Stochastic Average

Today, InMed Pharmaceuticals Inc’s raw stochastic average for the past 50 days stands at 37.40%, indicating a rise from the raw stochastic average of the last 20 days, which was 32.57%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 56.08% and 52.18% respectively.

INM Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 11.01% this year. Over the last six months, there has been a stronger performance of -0.60%. The price of INM fallen by 1.39% during the last 30 days period. For the last 5-days stocks have improved 24.69%.

Most Popular